SCHEMBL7526238

SCHEMBL7526238

CCOC(Cc1ccc(OCCN2CCOc3ccccc32)cc1)C(=O)O.OCCNc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.59
PPARA Q07869 17/20 0.59
PPARD Q03181 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14265753 0.91 PPARG (0.69) PPARGPPARAPPARD
SCHEMBL5107356 0.91 PPARG (0.69) PPARGPPARAPPARD
SCHEMBL1868253 0.91 PPARG (0.61) PPARGPPARAPPARD
SCHEMBL1858219 0.87 PPARG (0.54) PPARGPPARAPPARD
SCHEMBL1860021 0.87 PPARG (0.64) PPARGPPARAPPARD
N-Benzylmethylamine SCHEMBL7525090 0.86 PPARG (0.61) PPARGPPARAPPARD
Tromethamine SCHEMBL7522757 0.86 PPARG (0.61) PPARGPPARAPPARD
SCHEMBL5101320 0.85 PPARG (0.56) PPARGPPARAPPARD
SCHEMBL4827197 0.85 PPARG (0.54) PPARGPPARAPPARD
SCHEMBL4823788 0.85 PPARG (0.54) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020142993-A1 Pharmaceutically acceptable salts of bicyclic compounds DR. REDDY'S LABORATORIES LTD. 2002-10-03 US claimed
WO-2002030914-A1 SALTS OF BENZOTHIAZINE AND BENZOXAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S RESEARCH FOUNDATION (IN) 2002-04-18 WO claimed
US-20020142993-A1 Pharmaceutically acceptable salts of bicyclic compounds DR. REDDY'S LABORATORIES LTD. 2002-10-03 US disclosed
WO-2002030914-A1 SALTS OF BENZOTHIAZINE AND BENZOXAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S RESEARCH FOUNDATION (IN) 2002-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020142993-A1 Pharmaceutically acceptable salts of bicyclic compounds CYP3A43, ABCG2, SLC10A1 PPARG 411/4885PPARA 1234/4885PPARD 471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.